lenalidomid glenmark 10 mg
glenmark pharmaceuticals s.r.o., Česká republika - lenalidomid - 59 - immunopraeparata
lenalidomid glenmark 5 mg
glenmark pharmaceuticals s.r.o., Česká republika - lenalidomid - 59 - immunopraeparata
lignaron 7,5 mg tvrdé kapsuly
egis pharmaceuticals plc, maďarsko - lenalidomid - 59 - immunopraeparata
lignaron 5 mg tvrdé kapsuly
egis pharmaceuticals plc, maďarsko - lenalidomid - 59 - immunopraeparata
lignaron 25 mg tvrdé kapsuly
egis pharmaceuticals plc, maďarsko - lenalidomid - 59 - immunopraeparata
lignaron 20 mg tvrdé kapsuly
egis pharmaceuticals plc, maďarsko - lenalidomid - 59 - immunopraeparata
lignaron 2,5 mg tvrdé kapsuly
egis pharmaceuticals plc, maďarsko - lenalidomid - 59 - immunopraeparata
lignaron 15 mg tvrdé kapsuly
egis pharmaceuticals plc, maďarsko - lenalidomid - 59 - immunopraeparata
lignaron 10 mg tvrdé kapsuly
egis pharmaceuticals plc, maďarsko - lenalidomid - 59 - immunopraeparata
idefirix
hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - imunosupresíva - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.